SCHEMBL22772177

SCHEMBL22772177

Cn1ccc(-c2cccnn2)c(-c2ccccc2)c1=O

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ BRD4 O60885 5/20 0.40
▸ MAT2A P31153 2/20 0.38
▸ PTGS2 P35354 2/20 0.36
▸ CDK8 P49336 1/20 0.35
▸ ACVR1 Q04771 1/20 0.35
▸ SLC11A2 P49281 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ GAA P10253 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ TGFBR1 P36897 1/20 0.34
▸ DHPS P49366 1/20 0.34
▸ PTGS1 P23219 1/20 0.34
▸ BTK Q06187 1/20 0.34
▸ KMT2A Q03164 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ DHODH Q02127 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22772179 0.80 DHPS (0.37) KDM4EALDH1A1BRD4MAT2APTGS2
Hydrochloric Acid SCHEMBL23292007 0.71 PDPK1 (0.47) KDM4EALDH1A1SMN1; SMN2MAT2APTGS2
SCHEMBL18136496 0.70 BRD4 (0.49) KDM4EALDH1A1SMN1; SMN2BRD4CDK8
SCHEMBL28667607 0.69 GABRG2 (0.38) BRD4HTR2CTGFBR1KMT2AHDAC4
SCHEMBL26224303 0.69 GABRG2 (0.39) ALDH1A1BRD4HTR2CTGFBR1KMT2A
SCHEMBL15717101 0.68 ALDH1A1 (0.46) KDM4EALDH1A1SMN1; SMN2BRD4CDK8
SCHEMBL121970 0.68 RAB9A (0.50) SMN1; SMN2KMT2AHDAC4DHODH
SCHEMBL29959678 0.68 RAB9A (0.50) SMN1; SMN2KMT2AHDAC4DHODH
Hydrochloric Acid SCHEMBL9513928 0.66 HDAC4 (0.49) SMN1; SMN2KMT2AHDAC4DHODH
Water SCHEMBL11877808 0.66 HDAC4 (0.49) SMN1; SMN2KMT2AHDAC4DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230025130-A1 METHODS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2023-01-26 — — US disclosed
US-11129829-B2 Methods for modulating splicing SKYHAWK THERAPEUTICS, INC. (US) 2021-09-28 — — US disclosed
US-20200390765-A1 METHODS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2020-12-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11129829-B2 Methods for modulating splicing RBM17, SNRPE, SNRPB2 KDM4E 2789/4885ALDH1A1 3474/4885SMN1; SMN2 145/4885
US-20230025130-A1 METHODS FOR MODULATING SPLICING RBM17, SNRPE, SNRPB2 KDM4E 2789/4885ALDH1A1 3474/4885SMN1; SMN2 145/4885
US-20200390765-A1 METHODS FOR MODULATING SPLICING RBM17, SNRPE, SNRPB2 KDM4E 2789/4885ALDH1A1 3474/4885SMN1; SMN2 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback